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Celeste Caruso Bavisotto, Antonella Marino Gammazza, Francesca Rappa,  
Alberto Fucarino, Alessandro Pitruzzella, Sabrina David, Claudia Campanella 
Cell-to-cell communication is imperative for life. Intercellular communications are medi-
ated through “sending” and “receiving” information via the secretion and subsequent 
receptor-mediated detection of biomolecular species (1). Each type of cell exhibits a par-
ticular set of receptors that allows it to respond to a corresponding number of signal 
molecules produced by other cells and these ligands act in combination to influence cell 
behavior (1). There are many pathways of intercellular communication such as the pres-
ence of signaling molecules on plasma membranes or secretion of soluble ligands. A 
number of evidences have now demonstrated new mechanisms of intercellular interaction 
through lipid vesicles (2, 3).  
The extracellular vesicles are constituted by a lipid bilayer that contains in its lumen both 
transmembrane and free proteins, RNA and microRNA; based on their composition and 
size these vesicles can be categorized into various classes such as exosomes, apoptotic 
bodies, microparticles, etc. (4). In recent years many studies have focused on exosomes, 
a particularly important class of extracellular vesicles (5). Exosomes are 30-100 nm wide 
membranous vesicles first described in 1984 by Pan and Johnstone in maturing mammal-
ian reticulocytes as a mechanism for removal of plasma membrane proteins (6); over the 
years they have been observed to be secreted into the culture medium from a large num-
ber of cell types, including T cells, B cells, dendritic cells, platelets, epithelial cells and 
cancer cells (3, 5, 7- 9).  
Recent studies have reported the isolation and characterization of these vesicles in 
Invited Commentary 
©
 
E
U
R
O
M
E
D
I
T
E
R
R
A
N
E
A
N
 
B
I
O
M
E
D
I
C
A
L
 
J
O
U
R
N
A
L
 
 
2
0
1
3
, 
8
(
2
2
)
:1
3
7
-
1
3
9
. 
D
O
I
: 
1
0
.3
2
6
9
/
1
9
7
0
-
5
4
9
2
.2
0
1
3
.8
.2
2
 
A
v
a
i
l
a
b
l
e
 
o
n
-
l
i
n
e
 
a
t
: 
h
t
t
p
:/
/
w
w
w
.e
m
b
j
.o
r
g
 
SUMMARY 
With this invited commentary we want to draw the attention of young medical doctors, 
the main readers of this journal, towards the existence and importance of a group of 
nanovesicles released by human cells: the exosomes. These vesicles are incontinently se-
creted as a mean of cell-to-cell communication. They are involved in a number of physiol-
ogic processes as well as in the pathogenesis of, virtually, all human diseases. They can 
be isolated from all biological fluids, like blood, urine, sweat, sperm, crevicular fluid, bile, 
etc., and their composition in terms of proteins, RNA and lipids is different in pathology 
that in physiologic conditions. It is therefore possible to predict that they will become an 
important diagnostic and therapeutic tool in medicine.  
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physiological fluids such as normal urine, 
plasma, bronchoalveolar lavage and syno-
vial fluid (4). Exosomes are released into 
the extracellular space after the merging of 
the endosomes with the cell membrane. 
Early endosomes become part of the mul-
tivesicular bodies (MVBs) that undergo a 
maturing process that provides for a grad-
ual change of the protein composition of 
the vesicles contained within; exosomes 
represent the intraluminal vesicles of MVBs 
that merge with the plasma membrane 
resulting in the exocytosis of the vesicles 
contained (10, 11). Lipid rafts or choles-
terol and sphingolipid microdomains, en-
riched in plasma membranes, are shown to 
play an important role in the formation of 
exosomes (10).  
Depending on the cell types from which 
they are derived, exosomes play a role in 
diverse physiologic and pathological proc-
esses serving as a novel and more intricate 
form of cell-cell communication. Tumor 
cells also produce exosomes, evidently 
abundant in culture and malignant effu-
sions (11). Many studies have demon-
strated that exosomes play a role in im-
mune system activation during cancer 
progression and also in the tumor micro-
environment (11). Among the proteins that 
can be carried by exosomes there are 
those belonging to the family of molecular 
chaperones. 
Molecular chaperones, many of which be-
long to the Heat shock proteins (Hsps) 
family, are important players in protein 
homeostasis and cell tissue physiology, as 
well as in protection against stressors.  
They assist nascent protein in folding cor-
rectly or in refolding if partially denatured 
and they also drive protein translocation 
across membranes  or,  if proteins are 
damaged, toward degradation (12, 13). 
Moreover, molecular chaperones have 
other roles such as participation in im-
mune system regulation (14, 15), cell dif-
ferentiation (16), apoptosis and carcino-
genesis (17-19). Hsps are normally consid-
ered intracellular or associated to some 
organelles, but many studies have shown 
that they can also occur in extracellular 
and in non-canonical sites inside the cells 
(20).  
Exosomes have been described as potent 
export vehicles for Hsps from the en-
dosomal compartment into the extracellu-
lar environment (21). For example, Hsp60, 
is considered a mitochondrial chaperone 
that is essential for the mitochondrial pro-
tein  physiology (22). The  range of func-
tions attributed to Hsp60 has recently 
expanded and in particular it is evident 
that it plays a role in immune system regu-
lation (15), apoptosis (17) and also carcino-
genesis (19). Its levels have been found 
increased in a number of tumors (19) and 
it has been hypothesized that Hsp60 over-
expression have an important role on can-
cer development and progression (19). 
There is increasing evidence that Hsp60 is 
localized on plasma membranes and also 
outside the cell where it mediates interac-
tions between cells (9, 23, 24).  
In recent studies it has been demonstrated 
that Hsp60 is released via exosomes from 
cardiac myocites in both basal state and 
following mild stress (21). Moreover we 
have demonstrated that human tumor cells 
can actively release Hsp60 by a nonconven-
tional secretion mechanism: the lipid raft-
exosome pathway (9, 23). These findings 
suggest a new role for extracellular Hsp60 
in the cross talk between tumor cells and 
the immune system (23, 24).  
Expression of Hsp60 on the surface of 
exosomes, released by tumor cells, may be 
considered as a danger signal for the im-
mune system. The molecular composition 
of exosomes reflects the specialized func-
tions of the original cells (25). Through 
their ability to bind target cells, they are 
likely to modulate selected cellular activi-
ties.  
The presence in accessible fluids of 
exosomes containing biomarkers, such as 
Hsp60, may be useful for the early detec-
tion of a disease status. Exosomes offer 
huge opportunities for clinical applications 
that include their use as potential novel 
biomarkers for the diagnosis or prognosis 
of different diseases or for therapeutic 
application and drug delivery.  
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